Comparison results
| Results: Differences General | ✘D72.1 | ✘Nematodes | ||||
| Related research | Analogs | Analogs | ||||
| ||||||
| Distinctive symptoms | ||||||
| Register, to see more distinctive signs of diseases and studies | 10% | — | ||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||
| basophilia | 9% | — | ||||
| rectal prolapse in children | — | 73% | ||||
| neutrophilosis | 7% | — | ||||
| helminths | — | 68% | ||||
| hematocrit is reduced | 7% | — | ||||
| dry rashes on the ears | — | 66% | ||||
| lymphocytosis | 7% | — | ||||
| scabies | — | 62% | ||||
| stick neutrophils increased | 7% | — | ||||
| helminthiasis in children | — | 60% | ||||
| hypersthenuria | 6% | — | ||||
| inversion of the intestines | — | 53% | ||||
| with reactive protein increased | 6% | — | ||||
| skin mite | — | 53% | ||||
| neutropenia | 6% | — | ||||
| prolapse of the rectum | — | 53% | ||||
| increased ESR | 6% | — | ||||
| worms in the feces | — | 51% | ||||
| lymphopenia | 5% | — | ||||
| diarrhea in a child | — | 51% | ||||
| mchc reduced | 5% | — | ||||
| capillariosis | — | 48% | ||||
| protein with increased | 5% | — | ||||
| worse standing | — | 46% | ||||
| for an increase in ige | 5% | — | ||||
| eosinophilia | 2% | 47% | ||||
| increased alt | 4% | — | ||||
| nematodes | — | 44% | ||||
| enlarged liver | 4% | — | ||||
| necatorosis | — | 39% | ||||
| increased | 4% | — | ||||
| pinworms | — | 32% | ||||
| piebaldism | 4% | — | ||||
| strongyloidosis | — | 31% | ||||
| anemia | 3% | — | ||||
| trichinosis | — | 31% | ||||
| albinism | 3% | — | ||||
| leukocytosis | 6% | 36% | ||||
| chediak-higashi syndrome | 3% | — | ||||
| filariasis | — | 29% | ||||
| fever weakness | 2% | — | ||||
| angiostrongylosis | — | 28% | ||||
| smart baby | 2% | — | ||||
| tropical pulmonary eosinophilia | — | 28% | ||||
| enlargement of the liver and spleen | 2% | — | ||||
| syngamidosis | — | 28% | ||||
| sensitive child | 2% | — | ||||
| loaoz | — | 28% | ||||
| photophobia | 2% | — | ||||
| gnathostomosis | — | 28% | ||||
| intellectual disabilities in children | 2% | — | ||||
| mansonellosis | — | 28% | ||||
| hepatosplenomegaly | 2% | — | ||||
| anisakidosis | — | 28% | ||||
| neuroses in children | 2% | — | ||||
| dracunculiasis | — | 28% | ||||
| convulsive syndrome in children | 2% | — | ||||
| ascariasis | — | 27% | ||||
| epilepsy in children | 2% | — | ||||
| ascaris | — | 26% | ||||
| immunodeficiency | 2% | — | ||||
| gongilonematosis | — | 25% | ||||
| primary immunodeficiency | 2% | — | ||||
| ankylostomidosis | — | 25% | ||||
| tendency to bleed | 2% | — | ||||
| esophagostomosis | — | 25% | ||||
| lymphadenitis in children | 2% | — | ||||
| ternidentosis | — | 25% | ||||
| pancytopenia | 2% | — | ||||
| acanthocheilonematosis | — | 25% | ||||
| hemophagocytic syndrome | 2% | — | ||||
| dioctophimosis | — | 25% | ||||
| takes methotrexate | 2% | — | ||||
| brugiosis | — | 25% | ||||
| hemorrhagic fevers | 2% | — | ||||
| vuhereriosis | — | 25% | ||||
| neurological disorders | 2% | — | ||||
| tominksoz | — | 25% | ||||
| purulent lymphadenitis | 2% | — | ||||
| trichurosis | — | 23% | ||||
| onchocerciasis | — | 22% | ||||
| leffler syndrome | — | 18% | ||||
| pulmonary eosinophilic infiltrate | — | 18% | ||||
| interstitial pneumonia | — | 15% | ||||
| interstitial lung diseases | — | 14% | ||||
| pneumonia | — | 12% | ||||
| high temperature | 1% | 11% | ||||
| feeling of heat | 1% | 11% | ||||
| impaired lung function | — | 10% | ||||
| oncology | 1% | 10% | ||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
